Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study

Seth E. Karol, Jeffrey E. Rubnitz, Jeffery M. Klco et al.|The Lancet Oncology|2020

Cited by 167